Vivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTM
18. Oktober 2024 08:30 ET
|
Vivos Inc.
Richland WA N, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. Certifies new clinic for IsoPet therapy. NorthStar Vets - Veterinary Emergency & Trauma Specialty...
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
28. Juni 2024 10:15 ET
|
Vivos Inc.
Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing...
Vivos Inc. Expands IsoPet® Trademark Protection
27. Mai 2021 09:30 ET
|
Vivos Inc.
Richland, WA, May 27, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL). Vivos Inc. previously filed to extend its IsoPet® trademark protection internationally. We are pleased to report that the...
Vivos Inc. Issues Letter to Its Shareholders
01. Februar 2019 16:05 ET
|
Vivos Inc.
Richland WA, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL). The Board of Directors of Vivos Inc. (OTCPINK: RDGL), a pharmaceutical company in the process of researching and...